Align Technology Inc. (ALGN): Today's Featured Health Services Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Align Technology ( ALGN) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day up 0.7%. By the end of trading, Align Technology fell $2.07 (-4.3%) to $45.80 on heavy volume. Throughout the day, 1,553,663 shares of Align Technology exchanged hands as compared to its average daily volume of 628,900 shares. The stock ranged in price between $45.60-$47.02 after having opened the day at $46.76 as compared to the previous trading day's close of $47.87. Other companies within the Health Services industry that declined today were: Edap TMS ( EDAP), down 7.9%, Pingtan Marine Enterprise ( PME), down 7.7%, American Caresource Holdings ( ANCI), down 5.5% and Misonix ( MSON), down 5.2%.

Align Technology, Inc. operates as a medical device company primarily in the United States and internationally. Align Technology has a market cap of $3.8 billion and is part of the health care sector. Shares are up 71.1% year to date as of the close of trading on Thursday. Currently there are 6 analysts that rate Align Technology a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Align Technology as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, increase in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity.

On the positive front, Pro-Dex ( PDEX), up 20.1%, InspireMD ( NSPR), up 18.8%, Fonar Corporation ( FONR), up 17.2% and Health Insurance Innovations ( HIIQ), up 10.9% , were all gainers within the health services industry with Thermo Fisher Scientific ( TMO) being today's featured health services industry leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

More from Markets

3 Things Investors Must Know for Monday

3 Things Investors Must Know for Monday

U.S. Earnings On Pace for Best Season in Two Decades but Tech Giants Await

U.S. Earnings On Pace for Best Season in Two Decades but Tech Giants Await

Alphabet Earnings and 4 Other Business Stories You Must Know Monday Morning

Alphabet Earnings and 4 Other Business Stories You Must Know Monday Morning

Alphabet Earnings, Bond Yields Rise, Akorn Plunges - 5 Things You Must Know

Alphabet Earnings, Bond Yields Rise, Akorn Plunges - 5 Things You Must Know

Global Stocks Slip as 3% 10-Year Yields, Bad Tech News Unsettle Markets

Global Stocks Slip as 3% 10-Year Yields, Bad Tech News Unsettle Markets